Target intelligence / Profile preview

Paullinia cupana

Molecular classification
Botanical extract, Natural product source
01

Overview

Guarana (Paullinia cupana) is a climbing plant native to the Amazon basin, most notable for its seeds which contain a high concentration of caffeine, often twice that found in coffee beans (NIH, 2023). It is not a specific therapeutic target (such as a single receptor or enzyme) but is rather a complex botanical source of multiple bioactive compounds, including methylxanthines and tannins (Wikipedia, 2024). The physiological effects of Guarana are primarily driven by caffeine's antagonism of adenosine receptors, which stimulates the central nervous system and enhances cognitive alertness and physical performance (PubMed, 2019). Additionally, its polyphenol content, specifically catechins and epicatechins, contributes to its antioxidant properties and may play a role in metabolic regulation (PubChem). In the pharmaceutical and nutraceutical industries, Guarana is frequently used in weight-loss supplements and energy drinks, though its complex mixture makes it a source of drugs rather than a target for them.

Other names
GuaranaBrazilian cocoaPaullinia sorbilisUaraná
02

Mechanism of action

The primary bioactive constituent of Guarana is caffeine, which acts as a non-selective antagonist of adenosine A1 and A2A receptors in the brain, thereby preventing the inhibitory effects of adenosine and increasing the release of neurotransmitters like dopamine and norepinephrine (StatPearls, 2023). It also inhibits phosphodiesterase enzymes, leading to increased levels of intracellular cAMP, which promotes lipolysis and thermogenesis (PubMed, 2020).

03

Biological functions

Central nervous system stimulationThermogenesisAntioxidant activityLipolysis induction
04

Disease associations

ObesityFatigueCognitive impairment
05

Safety considerations

InsomniaTachycardiaAnxietyHypertensionGastrointestinal irritationDrug-drug interactions with other stimulants
06

Interacting drugs

Caffeine

2 more in the full profile.

Beyond the preview

Go deeper on Paullinia cupana.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paullinia cupana.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call